Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes

How can we strengthen primary care-led liver health care? In this episode, we chat with Dr Helen Jarvis who led the recently published Commission on the role of primary care in response to the global liver disease syndemic. Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00015-4/fulltext The Lancet Gastroenterology & Hepatology in conversation with... is part of the Lancet Group podcast offering. Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall Podcast editing: Matteo Simonetti Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. Find the best science for better lives at https://www.thelancet.com/Follow us today at...x.com/LancetGastroHepbsky.app/lancetgastrohep.bsky.social Linkedin.comInstagramFacebookyoutube.com/thelancettv

Could repeated liver stiffness measurement offer a practical approach to population-based liver fibrosis screening? In this episode, we speak with Pere Ginès about the LiverScreen study, which analysed changes in liver stiffness over time across three European cohorts and identified the risk factors associated with these changes. Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00091-9/fulltext The Lancet Gastroenterology & Hepatology in conversation with... is part of the Lancet Group podcast offering. Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall Podcast editing: Matteo Simonetti Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. Find the best science for better lives at https://www.thelancet.com/Follow us today at...x.com/LancetGastroHepbsky.app/lancetgastrohep.bsky.social Linkedin.comInstagramFacebookyoutube.com/thelancettv

In children with Crohn’s disease who achieve remission through exclusive enteral nutrition, what's the optimal dietary therapy to maintain remission without the use of medication or surgery? Frank Ruemmele (Université Paris Cité) talks through the CD-Hope randomised controlled trial and its implications for clinical practice. Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00262-6/fulltext The Lancet Gastroenterology & Hepatology in conversation with... is part of the Lancet Group podcast offering. Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall Podcast editing: Matteo Simonetti Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. Find the best science for better lives at https://www.thelancet.com/Follow us today at...x.com/LancetGastroHepbsky.app/lancetgastrohep.bsky.social Linkedin.comInstagramFacebookyoutube.com/thelancettv

Steatotic liver disease labels hinge on alcohol intake, but self-report is often inaccurate. In this episode, Aleksander Krag (Odense University Hospital) discusses a large Danish study using phosphatidylethanol (PEth), a direct blood biomarker of recent drinking, showing substantial underestimation and potential reclassification from MASLD to MetALD/ALD. Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00187-6/fulltext Medical imaging an...

Can bacteria-free, sterile faecal filtrate match conventional faecal microbiota transplantation for recurrent C difficile infection? Dina Kao (University of Alberta) unpacks a landmark multicentre trial that tested this hypothesis, and we discuss what it tells us about the role of living organisms in the therapeutic effects of microbiota-based therapies. Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00190-6/fulltext Continue this conve...